Clinical Trials Browser

Phase 2 × kang-lai-te × Clear all

NCT03101514 2021-06-23

Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study

Phase 2 Completed

53 enrolled 11 charts

Head & NeckOther

Head and Neck Neoplasms, Neoplasms, Mucositis

NCT01640730 2014-01-16

Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung